|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/96 | |
| A61K 38/48 | |||
| A61K 38/36 |
| (11) | Patento numeris | 2591099 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11738538.5 |
| Europos patento paraiškos padavimo data | 2011-07-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/043597 |
| Data | 2011-07-11 |
| (87) | Numeris | WO 2012/006633 |
| Data | 2012-01-12 |
| (30) | Numeris | Data | Šalis |
| 201161442055 P | 2011-02-11 | US | |
| 201161467880 P | 2011-03-25 | US | |
| 363183 P | 2010-07-09 | US | |
| 201161491762 P | 2011-05-31 | US | |
| 201161442150 P | 2011-02-11 | US | |
| 363186 P | 2010-07-09 | US | |
| 201161442029 P | 2011-02-11 | US |
| (72) |
SALAS, Joe, US
PETERS, Robert, US
BITONTI, Alan, US
|
| (73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
| (54) | CHIMERIC CLOTTING FACTORS |
| CHIMERIC CLOTTING FACTORS |